Zogenix to Participate in Cantor Fitzgerald Healthcare Conference
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Zogenix (ZGNX) Appoints Two New Executives
July 6, 2015 8:33 AM EDTZogenix (Nasdaq: ZGNX) announced the appointments of Gail M. Farfel, Ph.D., as Executive Vice President and Chief Development Officer, and Thierry Darcis, M.D., M.B.A., as Executive Vice President and General Manager, Europe.
"The addition of two highly experienced product development and commercial leaders in the orphan CNS disease category further advances our core strategic focus on the Company's late-stage CNS product development pipeline," said Stephen Farr, Chief Executive Officer of Zogenix. "We are extremely pleased to have both Gail and Thierry join Zogenix at this exciting time in the... More
